UY24387A1 - Dihidrato del (2r,3s)-3-ter-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4,10beta-diacetoxi-2alfa-benzoiloxi-5beta, 20-epoxi-1-hidroxi-9-oxo-19-norciclopro-pa(g)tax-11-eno-13-alfa-ilo y su procedimiento de preparación. - Google Patents

Dihidrato del (2r,3s)-3-ter-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4,10beta-diacetoxi-2alfa-benzoiloxi-5beta, 20-epoxi-1-hidroxi-9-oxo-19-norciclopro-pa(g)tax-11-eno-13-alfa-ilo y su procedimiento de preparación.

Info

Publication number
UY24387A1
UY24387A1 UY24387A UY24387A UY24387A1 UY 24387 A1 UY24387 A1 UY 24387A1 UY 24387 A UY24387 A UY 24387A UY 24387 A UY24387 A UY 24387A UY 24387 A1 UY24387 A1 UY 24387A1
Authority
UY
Uruguay
Prior art keywords
hydroxy
10beta
phenylpropionate
tax
oxo
Prior art date
Application number
UY24387A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9485512&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY24387(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of UY24387A1 publication Critical patent/UY24387A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Nuevo compuesto caracterizado porque es el dihidrato de (2R,3S)-3-ter-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4,10beta-diacetoxi-2alfa-benzoiloxi-5beta, 20-epoxi-1-hidroxi-9-oxo-19-norciclopropa(g)tax-11-eno-13alfa-ilo; que presenta propiedades anticancerosas y antileucémicas.
UY24387A 1995-12-14 1996-12-02 Dihidrato del (2r,3s)-3-ter-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4,10beta-diacetoxi-2alfa-benzoiloxi-5beta, 20-epoxi-1-hidroxi-9-oxo-19-norciclopro-pa(g)tax-11-eno-13-alfa-ilo y su procedimiento de preparación. UY24387A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9514841A FR2742438B1 (fr) 1995-12-14 1995-12-14 Dihydrate du (2r,3s)-3-tert-butoxycarbonylamino-2-hydroxy- 3-phenylpropionate de 4,10beta-diacetoxy-2alpha-benzoyloxy- 5beta,2o-epoxy-1-hydroxy-9-oxo-19-nor-cyclopropa(g)tax-11- ene-13alpha-yle, et son procede de preparation

Publications (1)

Publication Number Publication Date
UY24387A1 true UY24387A1 (es) 2001-08-27

Family

ID=9485512

Family Applications (1)

Application Number Title Priority Date Filing Date
UY24387A UY24387A1 (es) 1995-12-14 1996-12-02 Dihidrato del (2r,3s)-3-ter-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4,10beta-diacetoxi-2alfa-benzoiloxi-5beta, 20-epoxi-1-hidroxi-9-oxo-19-norciclopro-pa(g)tax-11-eno-13-alfa-ilo y su procedimiento de preparación.

Country Status (37)

Country Link
EP (1) EP0876361B1 (es)
JP (1) JP4059351B2 (es)
KR (1) KR100429330B1 (es)
CN (1) CN101113143A (es)
AR (1) AR004380A1 (es)
AT (1) ATE204573T1 (es)
AU (1) AU713086C (es)
BG (1) BG63010B1 (es)
BR (1) BR9611957A (es)
CA (1) CA2236545C (es)
CO (1) CO4810227A1 (es)
CZ (1) CZ288998B6 (es)
DE (1) DE69614716T2 (es)
DK (1) DK0876361T3 (es)
DZ (1) DZ2140A1 (es)
EA (1) EA000668B1 (es)
ES (1) ES2162123T3 (es)
FR (1) FR2742438B1 (es)
GR (1) GR3036437T3 (es)
HU (1) HU224962B1 (es)
IL (1) IL124766A (es)
IN (1) IN185809B (es)
MY (1) MY115886A (es)
NO (1) NO317356B1 (es)
NZ (1) NZ323964A (es)
OA (1) OA11012A (es)
PL (1) PL187613B1 (es)
PT (1) PT876361E (es)
RO (1) RO115880B1 (es)
SK (1) SK282512B6 (es)
TN (1) TNSN96157A1 (es)
TR (1) TR199801087T2 (es)
TW (1) TW358093B (es)
UA (1) UA55401C2 (es)
UY (1) UY24387A1 (es)
WO (1) WO1997021695A1 (es)
ZA (1) ZA9610200B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102851740A (zh) * 2011-06-30 2013-01-02 复旦大学 一种氟代多烯紫杉醇晶体及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2698871B1 (fr) * 1992-12-09 1995-02-24 Rhone Poulenc Rorer Sa Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
WO1997021695A1 (fr) 1997-06-19
BR9611957A (pt) 1999-02-17
TNSN96157A1 (fr) 2005-03-15
OA11012A (fr) 2003-03-06
TR199801087T2 (xx) 1998-09-21
SK79098A3 (en) 1998-11-04
ATE204573T1 (de) 2001-09-15
NZ323964A (en) 2000-01-28
EA199800452A1 (ru) 1998-12-24
EA000668B1 (ru) 2000-02-28
TW358093B (en) 1999-05-11
HUP9904048A1 (hu) 2001-04-28
DE69614716T2 (de) 2002-06-27
DZ2140A1 (fr) 2002-07-23
GR3036437T3 (en) 2001-11-30
PT876361E (pt) 2001-11-30
DE69614716D1 (de) 2001-09-27
HU224962B1 (en) 2006-04-28
IL124766A0 (en) 1999-01-26
FR2742438B1 (fr) 1998-01-16
KR19990072107A (ko) 1999-09-27
EP0876361A1 (fr) 1998-11-11
MX9804604A (es) 1998-10-31
MY115886A (en) 2003-09-30
PL187613B1 (pl) 2004-08-31
DK0876361T3 (da) 2001-10-08
NO317356B1 (no) 2004-10-18
CA2236545A1 (fr) 1997-06-19
AU1101397A (en) 1997-07-03
BG102535A (en) 1999-08-31
NO982561D0 (no) 1998-06-04
KR100429330B1 (ko) 2005-01-13
BG63010B1 (bg) 2001-01-31
IN185809B (es) 2001-05-05
UA55401C2 (uk) 2003-04-15
CZ183098A3 (cs) 1998-09-16
HUP9904048A3 (en) 2001-08-28
SK282512B6 (sk) 2002-10-08
JP4059351B2 (ja) 2008-03-12
NO982561L (no) 1998-06-04
AR004380A1 (es) 1998-11-04
IL124766A (en) 2001-03-19
FR2742438A1 (fr) 1997-06-20
CN101113143A (zh) 2008-01-30
CZ288998B6 (cs) 2001-10-17
EP0876361B1 (fr) 2001-08-22
ES2162123T3 (es) 2001-12-16
RO115880B1 (ro) 2000-07-28
ZA9610200B (en) 1997-06-23
JP2000501722A (ja) 2000-02-15
PL327451A1 (en) 1998-12-07
CA2236545C (fr) 2007-01-30
AU713086B2 (en) 1999-11-25
AU713086C (en) 2002-09-19
CO4810227A1 (es) 1999-06-30

Similar Documents

Publication Publication Date Title
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
FI964681A0 (fi) Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt
GEP20043375B (en) APRIL-Receptor (BCMA) and Use Thereof
BR9911724A (pt) Ciclosporina que tem um perfil de atividade melhorado
FI943749A (fi) Taksaanijohdannaisten fosfono-oksimetyylieetterit
ES2195970T3 (es) L-ribavirina y usos de la misma.
NO954320D0 (no) Lyosfærer omfattende gonadotropin
PT1036059E (pt) Derivados de adamantano
MX9602445A (es) Pigmentos dorados.
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
MX9601994A (es) Profarmacos de derivados de paclitaxel.
SE9604348D0 (sv) Användning av hydroxyguanidiner
SE9802937D0 (sv) Novel compounds
DE60133198D1 (en) Glykopeptidderivate mit carboxysacchariden
TR199802351T2 (xx) Topikal kullanım için bir veya birden fazla lokal anestezik ve anti-vajinit maddeler ihtiva eden anti-vajinit bileşimi.
MX9707974A (es) Derivados de 10, 13, 15-trioxatriciclo [9.2.1.1 9.6]-pentadecanona, procedimientos para su preparacion y medicamentos que contienen estos compuestos.
ES2172682T3 (es) Preparaciones desodorantes con contenido en quitosano, clorohidrato de aluminio e inhibidores de esterasa.
IL128500A (en) SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA[b] BENZOFURANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
UY24387A1 (es) Dihidrato del (2r,3s)-3-ter-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4,10beta-diacetoxi-2alfa-benzoiloxi-5beta, 20-epoxi-1-hidroxi-9-oxo-19-norciclopro-pa(g)tax-11-eno-13-alfa-ilo y su procedimiento de preparación.
DE69840673D1 (de) Modifizierte polysaccharide mit veränderter biologischer erkennung
AR020141A1 (es) Toxinas y genes pesticidas de cepas de bacillus laterosporus
AU4558201A (en) Taxane anticancer agents
DE69818492D1 (en) 7-methylthiooxomethyl- und 7-methylthiodioxomethyl-paclitaxele
ATE204286T1 (de) Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge
ES2141923T3 (es) Uso hipocolesterolemico, antiaterosclerotico e hipotrigliceridemico de derivados aminoacetilmercapto.

Legal Events

Date Code Title Description
VENC Patent expired

Effective date: 20161202